UK engineer Smiths Group confirmed on Friday it has been in talks to sell its medical division.
The group has been looking to sell the unit after an approach by potential buyers including San Diego-based healthcare business CareFusion, according to reports.
Smiths also rejected an approach by private equity group Apax to buy the division for £2.45bn in 2011, saying it did not reflect the value of the business.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Its medical division played a role in the first successful IVF treatment in 1978 with its embryo transfer.
In a statement Smiths said it has received a "preliminary approach" for the medical arm.
"This approach may or may not lead to a transaction," the company said.
"Discussions are at an early stage and a further announcement will be made as appropriate."
The division accounted for about a third of the parent group's headline operating profit last year and 28% of the company's £3bn revenues.
Smiths Medical provides devices for hospitals, emergency services, household use and in specialist medical units.
RD
-
December 2023 NS&I Premium Bond winners - check now to see what you’ve wonIf you hold money in NS&I Premium Bonds, you can check from today (2 December) to see if you have won in the December prize draw. Here’s how to check.
-
OpenAI – corporate drama unleashed
OpenAI, the firm behind ChatGPT, was in uproar as its boss was booted out, briefly snapped up by Microsoft and then brought back again.
